We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AVC.P market cap is 7.96M. The company's latest EPS is CAD -0.0576 and P/E is -2.78.
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -100k | 0 | -2.58M | -1.66M | -2.12M |
Net Income | -98k | -10k | -3.04M | -2.55M | -2.29M |
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 417k | 407k | 2.47M | 914k | 672k |
Total Liabilities | 3k | 3k | 112k | 718k | 2.39M |
Total Equity | 414k | 404k | 2.36M | 196k | -1.72M |
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -42k | -9k | -1.37M | -2.19M | -1.33M |
Investing | -409k | 10k | 382k | N/A | N/A |
Financing | 457k | N/A | 3.16M | 394k | 1.3M |
Market Cap | 7.96M |
Price to Earnings Ratio | -2.78 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 11.43 |
Price to Book Ratio | -3.7 |
Dividend Yield | - |
Shares Outstanding | 39.79M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 0.00% |
52 Week High | 0.20 |
52 Week Low | 0.20 |
Spread (Intraday) | 0.03 (15%) |
Company Name | American Vanadium Corp |
Address |
600, 815 8th avenue sw calgary, alberta T2P 3T2 |
Website | https://marvelbiotechnology.com |
Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions